Literature DB >> 32458005

Are disease-related pulmonary perfusion abnormalities detectable in COVID-19 patients? Suspicious findings in a lung perfusion SPECT performed for ruling out classical pulmonary embolism.

Roberto Sciagrà1, Federica Rubino2, Danilo Malandrino3, Nicoletta Bernardeschi2, Alberto Moggi Pignone4, Andrea Berni3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32458005      PMCID: PMC7248457          DOI: 10.1007/s00259-020-04868-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
PET/CT identifies FDG uptake, but presently there is no role for Nuclear Medicine in COVID-19 [1, 2]. However, thrombophilia is reported, and pulmonary emboli described [3-5]. In an 85-year-old man with dilated cardiomyopathy referred to the hospital because of dyspnea and cough, CT revealed bilateral pleural effusion with lower lobe ground glass opacities, but nasopharyngeal swab was negative for COVID-19, and hemoptysis plus persistence of severe hypoxemia with hypocapnia raised the suspicion of pulmonary embolism. Owing to elevated creatinine level, pulmonary perfusion SPECT was preferred, and initially reported as abnormal, but not diagnostic of acute embolism, because of uptake defects mainly coinciding with parenchymal anomalies. Subsequently, a second swab revealed infection by SARS-CoV-2. The patient was transferred to a COVID Unit, developed respiratory failure and fever (38.5°), and died 3 days later; last D-dimer was 1299 ng/mL and LDH 350 U/L. The lung scan was then reviewed after fusion with last CT. Figures 1 and 2 show the presence in the perfusion SPECT images (left panel, upper row: transaxial and coronal slices; lower row: sagittal slice and three-dimensional rendering) of small peripheral uptake defects (white arrows and arrowhead). In the corresponding CT images (right panel: same disposition, scout image in the lower right corner), the red arrows point to the parenchymal areas corresponding to the perfusion defects, which appear normally ventilated. These findings suggest that lung perfusion SPECT could identify perfusion abnormalities in early phase of COVID-19. Further studies are desirable to establish whether this could be helpful for these patients.
Fig. 1

Left panel: perfusion SPECT images, transaxial and coronal slices in the upper row, sagittal slice and three-dimensional rendering in the lower row. Small peripheral uptake defects are present (white arrows and arrowhead). Right panel: CT images, same slice disposition, plus scout image (lower right corner). The red arrows point to the parenchymal areas corresponding to the perfusion defects

Fig. 2

Same image disposition as in Fig. 1, showing similar findings in more basal fields

Left panel: perfusion SPECT images, transaxial and coronal slices in the upper row, sagittal slice and three-dimensional rendering in the lower row. Small peripheral uptake defects are present (white arrows and arrowhead). Right panel: CT images, same slice disposition, plus scout image (lower right corner). The red arrows point to the parenchymal areas corresponding to the perfusion defects Same image disposition as in Fig. 1, showing similar findings in more basal fields
  5 in total

1.  Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.

Authors:  Huan Han; Lan Yang; Rui Liu; Fang Liu; Kai-Lang Wu; Jie Li; Xing-Hui Liu; Cheng-Liang Zhu
Journal:  Clin Chem Lab Med       Date:  2020-06-25       Impact factor: 3.694

2.  Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.

Authors:  Ning Tang; Dengju Li; Xiong Wang; Ziyong Sun
Journal:  J Thromb Haemost       Date:  2020-03-13       Impact factor: 5.824

3.  PET imaging of COVID-19: the target and the number.

Authors:  E Guedj; A Verger; S Cammilleri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-04-17       Impact factor: 9.236

4.  Pulmonary embolism in patients with COVID-19: Time to change the paradigm of computed tomography.

Authors:  D C Rotzinger; C Beigelman-Aubry; C von Garnier; S D Qanadli
Journal:  Thromb Res       Date:  2020-04-11       Impact factor: 3.944

5.  18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases.

Authors:  Chunxia Qin; Fang Liu; Tzu-Chen Yen; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-02-22       Impact factor: 9.236

  5 in total
  3 in total

1.  COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness.

Authors:  Robin Cherian; Bharatendu Chandra; Moon Ley Tung; Alain Vuylsteke
Journal:  Eur Respir J       Date:  2020-08-27       Impact factor: 16.671

2.  COVID-19; beyond the obvious: how do we move forward?

Authors:  Afshin Nasoodi; Ciaran Johnston; Francesco Fraioli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-06-11       Impact factor: 9.236

Review 3.  Imaging Pulmonary Blood Vessels and Ventilation-Perfusion Mismatch in COVID-19.

Authors:  Dnyanesh N Tipre; Michal Cidon; Rex A Moats
Journal:  Mol Imaging Biol       Date:  2022-01-18       Impact factor: 3.484

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.